Jump to content

Drilldown: Medicines

Choose a table:


Medicines > fda max: 300 mg/quarter & halflife : 1-1.5 hours'"`UNIQ--ref-00000DE3-QINU`"' or ~27 days

Use the filters below to narrow your results.

generic:
None (1)
brand:
Vyepti (1)
classes:
Anti-CGRP ligand monoclonal antibody (1)
mechanism:
Humanized IgG1 monoclonal antibody binding CGRP peptide; IV infusion enables fastest onset of any CGRP mAb (1)
uses:
Preventive treatment of migraine in adults (1)
starting dose:
100 mg IV every 3 months; may increase to 300 mg IV every 3 months (1)
preparations:
100 mg/mL vial for IV infusion (1)
fda max: (Click arrow to add another value)
routes:
Intravenous infusion (1)
onset:
Effect demonstrated within 24 hours in some patients (1)
duration:
3-month dosing interval (1)
halflife: (Click arrow to add another value)
bioavailability:
100% (IV) (1)
pregnancy:
Limited data; avoid (1)
legal:
Rx (1)
Error in "where" parameter: the string "--" cannot be used within #cargo_query.

There are no results for this report.

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"